These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 10966203)

  • 1. Early radiation effects on the liver demonstrated on superparamegnetic iron oxide-enhanced T1-weighted MRI.
    Mori H; Yoshioka H; Ahmadi T; Saida Y; Ohara K; Itai Y
    J Comput Assist Tomogr; 2000; 24(4):648-51. PubMed ID: 10966203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging.
    Nasu K; Kuroki Y; Nawano S; Kuroki S; Tsukamoto T; Yamamoto S; Motoori K; Ueda T
    Radiology; 2006 Apr; 239(1):122-30. PubMed ID: 16493012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR imaging with i.v. superparamagnetic iron oxide: efficacy in the detection of focal hepatic lesions.
    Winter TC; Freeny PC; Nghiem HV; Mack LA; Patten RM; Thomas CR; Elliott S
    AJR Am J Roentgenol; 1993 Dec; 161(6):1191-8. PubMed ID: 8249724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of superparamagnetic iron oxide for MR imaging of liver injury: proton relaxation mechanisms and optimal MR imaging parameters.
    Tanimoto A; Mukai M; Kuribayashi S
    Magn Reson Med Sci; 2006 Jul; 5(2):89-98. PubMed ID: 17008765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular lesions with increased iron uptake on superparamagnetic iron oxide-enhanced magnetic resonance imaging in cirrhosis or chronic hepatitis: comparison of four magnetic resonance sequences for lesion conspicuity.
    Tanabe M; Ito K; Shimizu A; Fujita T; Onoda H; Yamatogi S; Washida Y; Matsunaga N
    Magn Reson Imaging; 2009 Jul; 27(6):801-6. PubMed ID: 19144487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using superparamagnetic iron oxide-enhanced MRI to differentiate metastatic hepatic tumors and nonsolid benign lesions.
    Kumano S; Murakami T; Kim T; Hori M; Okada A; Sugiura T; Noguchi Y; Kawata S; Tomoda K; Nakamura H
    AJR Am J Roentgenol; 2003 Nov; 181(5):1335-9. PubMed ID: 14573430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Focal liver lesions. A comparison between magnetic resonance under base conditions and after a superparamagentic contrast medium].
    Finazzo M; Midiri M; Gallo C; Bartolotta TV; Luca A
    Radiol Med; 1998 Jun; 95(6):599-607. PubMed ID: 9717542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging of macrophages in soft-tissue infection in rats: relationship between ultrasmall superparamagnetic iron oxide dose and MR signal characteristics.
    Lutz AM; Weishaupt D; Persohn E; Goepfert K; Froehlich J; Sasse B; Gottschalk J; Marincek B; Kaim AH
    Radiology; 2005 Mar; 234(3):765-75. PubMed ID: 15665219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superparamagnetic iron oxide-mediated hepatic signal intensity change in patients with and without cirrhosis: pulse sequence effects and Kupffer cell function.
    Tanimoto A; Yuasa Y; Shinmoto H; Jinzaki M; Imai Y; Okuda S; Kuribayashi S
    Radiology; 2002 Mar; 222(3):661-6. PubMed ID: 11867782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of well-differentiated hepatocellular carcinomas from other hepatocellular nodules in cirrhotic liver: value of SPIO-enhanced MR imaging at 3.0 Tesla.
    Park HS; Lee JM; Kim SH; Chang S; Kim SJ; Han JK; Choi BI
    J Magn Reson Imaging; 2009 Feb; 29(2):328-35. PubMed ID: 19161184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic metastases: detection with multi-detector row CT, SPIO-enhanced MR imaging, and both techniques combined.
    Onishi H; Murakami T; Kim T; Hori M; Iannaccone R; Kuwabara M; Abe H; Nakata S; Osuga K; Tomoda K; Passariello R; Nakamura H
    Radiology; 2006 Apr; 239(1):131-8. PubMed ID: 16484347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis.
    Reimer P; Jähnke N; Fiebich M; Schima W; Deckers F; Marx C; Holzknecht N; Saini S
    Radiology; 2000 Oct; 217(1):152-8. PubMed ID: 11012438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early detection of radiation-induced liver injury in rat by superparamagnetic iron oxide-enhanced MR imaging.
    Morimoto N; Ebara M; Kato H; Obata T; Fujita J; Kondo F; Tsujii H; Saisho H
    J Magn Reson Imaging; 1999 Apr; 9(4):573-8. PubMed ID: 10232517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SPIO-enhanced MR imaging of focal fatty liver lesions.
    Lwakatare F; Yamashita Y; Nakayama M; Takahashi M
    Abdom Imaging; 2001; 26(2):157-60. PubMed ID: 11178692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arterioportal shunts in cirrhotic patients: evaluation of the difference between tumorous and nontumorous arterioportal shunts on MR imaging with superparamagnetic iron oxide.
    Mori K; Yoshioka H; Itai Y; Okamoto Y; Mori H; Takahashi N; Saida Y
    AJR Am J Roentgenol; 2000 Dec; 175(6):1659-64. PubMed ID: 11090400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI in focal liver disease: a comparison of small and ultra-small superparamagnetic iron oxide as hepatic contrast agents.
    Mergo PJ; Engelken JD; Helmberger T; Ros PR
    J Magn Reson Imaging; 1998; 8(5):1073-8. PubMed ID: 9786144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of hepatomas in hyperplastic nodules induced in the rat liver: detection with superparamagnetic iron oxide-enhanced magnetic resonance imaging.
    Yamamoto H; Yamashita Y; Takahashi M
    Acad Radiol; 1996 Apr; 3(4):330-5. PubMed ID: 8796683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging.
    Lutz AM; Willmann JK; Goepfert K; Marincek B; Weishaupt D
    Radiology; 2005 Nov; 237(2):520-8. PubMed ID: 16192317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of SPIO-enhanced T1- and T2-weighted images for the differentiation of liver lesions: an ROC analysis].
    Stroszczynski C; Gaffke G; Gretschel S; Rambow A; Jost D; Schlecht I; Schneider U; Schicke B; Hohenberger P; Gebauer B; Felix R
    Rofo; 2003 Oct; 175(10):1368-75. PubMed ID: 14556106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benign hepatocellular tumors: MRI after superparamagnetic iron oxide administration.
    Grandin C; Van Beers BE; Robert A; Gigot JF; Geubel A; Pringot J
    J Comput Assist Tomogr; 1995; 19(3):412-8. PubMed ID: 7790551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.